Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CUE |
---|---|---|
09:32 ET | 22554 | 0.4502 |
09:34 ET | 13898 | 0.465 |
09:36 ET | 25430 | 0.465 |
09:38 ET | 43392 | 0.485 |
09:39 ET | 13051 | 0.499 |
09:41 ET | 45890 | 0.5666 |
09:43 ET | 50941 | 0.524 |
09:45 ET | 39555 | 0.5239 |
09:48 ET | 22499 | 0.5 |
09:50 ET | 1413 | 0.49 |
09:52 ET | 15099 | 0.505 |
09:54 ET | 9309 | 0.4904 |
09:56 ET | 12300 | 0.5 |
09:57 ET | 3555 | 0.5 |
09:59 ET | 9096 | 0.505 |
10:01 ET | 16950 | 0.5049 |
10:03 ET | 14000 | 0.5048 |
10:06 ET | 12867 | 0.5109 |
10:08 ET | 1637 | 0.5092 |
10:10 ET | 8464 | 0.5014 |
10:12 ET | 11400 | 0.51 |
10:14 ET | 431 | 0.511 |
10:15 ET | 2000 | 0.5116 |
10:17 ET | 14605 | 0.5013 |
10:19 ET | 3639 | 0.5001 |
10:21 ET | 5310 | 0.5039 |
10:24 ET | 10010 | 0.5072 |
10:26 ET | 12282 | 0.5089 |
10:28 ET | 7111 | 0.509 |
10:30 ET | 1000 | 0.504551 |
10:32 ET | 5630 | 0.5045 |
10:33 ET | 7712 | 0.509 |
10:35 ET | 6590 | 0.5002 |
10:37 ET | 16096 | 0.5075 |
10:39 ET | 10299 | 0.5149 |
10:42 ET | 500 | 0.5075 |
10:44 ET | 8530 | 0.5051 |
10:46 ET | 13969 | 0.5147 |
10:48 ET | 3400 | 0.515 |
10:50 ET | 1054 | 0.5126 |
10:51 ET | 46049 | 0.5315 |
10:53 ET | 27894 | 0.53755 |
10:55 ET | 11805 | 0.548 |
10:57 ET | 18306 | 0.5402 |
11:00 ET | 36787 | 0.5648 |
11:02 ET | 18798 | 0.5694 |
11:04 ET | 58496 | 0.55 |
11:06 ET | 3248 | 0.5459 |
11:08 ET | 2458 | 0.551001 |
11:09 ET | 8886 | 0.53 |
11:11 ET | 24703 | 0.5349 |
11:13 ET | 10847 | 0.5405 |
11:15 ET | 6215 | 0.5631 |
11:18 ET | 20126 | 0.57 |
11:20 ET | 48346 | 0.5801 |
11:22 ET | 44947 | 0.5525 |
11:24 ET | 2630 | 0.568699 |
11:26 ET | 15346 | 0.5528 |
11:27 ET | 10700 | 0.56 |
11:29 ET | 7841 | 0.5686 |
11:31 ET | 3400 | 0.56 |
11:33 ET | 5463 | 0.5642 |
11:36 ET | 250 | 0.5642 |
11:38 ET | 670 | 0.5647 |
11:40 ET | 11649 | 0.55 |
11:42 ET | 1200 | 0.5501 |
11:44 ET | 8475 | 0.5502 |
11:45 ET | 680 | 0.5536 |
11:47 ET | 11647 | 0.5731 |
11:49 ET | 44099 | 0.5751 |
11:51 ET | 3147 | 0.5858 |
11:54 ET | 2149 | 0.5729 |
11:56 ET | 25646 | 0.5729 |
11:58 ET | 26559 | 0.585 |
12:00 ET | 28415 | 0.62 |
12:02 ET | 141896 | 0.603 |
12:03 ET | 51205 | 0.6114 |
12:05 ET | 34819 | 0.586 |
12:07 ET | 32080 | 0.5958 |
12:09 ET | 41606 | 0.6299 |
12:12 ET | 21489 | 0.6046 |
12:14 ET | 20472 | 0.5947 |
12:16 ET | 17517 | 0.595401 |
12:18 ET | 16213 | 0.6051 |
12:20 ET | 18867 | 0.5937 |
12:21 ET | 6252 | 0.592288 |
12:23 ET | 24077 | 0.5817 |
12:25 ET | 63610 | 0.5878 |
12:27 ET | 21974 | 0.5898 |
12:30 ET | 12933 | 0.5984 |
12:32 ET | 3643 | 0.5703 |
12:34 ET | 110 | 0.570301 |
12:36 ET | 8624 | 0.5899 |
12:38 ET | 2926 | 0.587601 |
12:39 ET | 9957 | 0.5873 |
12:41 ET | 2619 | 0.573 |
12:43 ET | 3880 | 0.5852 |
12:45 ET | 947 | 0.5899 |
12:48 ET | 511 | 0.5883 |
12:50 ET | 2568 | 0.5861 |
12:52 ET | 3613 | 0.5874 |
12:54 ET | 25254 | 0.5981 |
12:56 ET | 22454 | 0.6005 |
12:57 ET | 6783 | 0.612 |
12:59 ET | 21983 | 0.6096 |
01:01 ET | 2599 | 0.6087 |
01:03 ET | 7704 | 0.5994 |
01:06 ET | 3087 | 0.5947 |
01:08 ET | 3391 | 0.5994 |
01:10 ET | 11318 | 0.6047 |
01:12 ET | 15513 | 0.6042 |
01:14 ET | 3850 | 0.6086 |
01:15 ET | 27282 | 0.6113 |
01:17 ET | 9679 | 0.6018 |
01:19 ET | 3862 | 0.6165 |
01:21 ET | 1028 | 0.6 |
01:24 ET | 27964 | 0.6294 |
01:26 ET | 108234 | 0.6393 |
01:28 ET | 101409 | 0.6384 |
01:30 ET | 107373 | 0.65 |
01:32 ET | 28968 | 0.637 |
01:33 ET | 29455 | 0.6469 |
01:35 ET | 12129 | 0.625801 |
01:37 ET | 24339 | 0.6201 |
01:39 ET | 2303 | 0.626101 |
01:42 ET | 25687 | 0.6203 |
01:44 ET | 24090 | 0.6201 |
01:46 ET | 18290 | 0.6005 |
01:48 ET | 32006 | 0.6151 |
01:50 ET | 14388 | 0.6236 |
01:51 ET | 11473 | 0.6296 |
01:53 ET | 5256 | 0.6186 |
01:55 ET | 5821 | 0.6101 |
01:57 ET | 2703 | 0.6191 |
02:00 ET | 2124 | 0.62375 |
02:02 ET | 10227 | 0.6407 |
02:04 ET | 3732 | 0.623 |
02:06 ET | 32957 | 0.6199 |
02:08 ET | 17678 | 0.61 |
02:09 ET | 27159 | 0.623 |
02:11 ET | 1409 | 0.6318 |
02:13 ET | 11496 | 0.626785 |
02:15 ET | 10437 | 0.6333 |
02:18 ET | 1310 | 0.6242 |
02:20 ET | 58960 | 0.6151 |
02:22 ET | 776 | 0.6155 |
02:24 ET | 5910 | 0.624 |
02:26 ET | 5306 | 0.6152 |
02:27 ET | 541 | 0.6152 |
02:29 ET | 1849 | 0.6242 |
02:31 ET | 11920 | 0.6242 |
02:33 ET | 39091 | 0.6151 |
02:36 ET | 3347 | 0.6259 |
02:38 ET | 240 | 0.6249 |
02:40 ET | 1709 | 0.6244 |
02:42 ET | 13970 | 0.6006 |
02:44 ET | 900 | 0.609 |
02:45 ET | 3222 | 0.61 |
02:47 ET | 12365 | 0.6235 |
02:49 ET | 46576 | 0.6349 |
02:51 ET | 7847 | 0.639 |
02:54 ET | 111130 | 0.65 |
02:56 ET | 12440 | 0.6351 |
02:58 ET | 14308 | 0.6485 |
03:00 ET | 16521 | 0.6567 |
03:02 ET | 43456 | 0.6579 |
03:03 ET | 38071 | 0.6581 |
03:05 ET | 22412 | 0.6501 |
03:07 ET | 10821 | 0.65 |
03:09 ET | 5500 | 0.646951 |
03:12 ET | 17714 | 0.656699 |
03:14 ET | 10760 | 0.658899 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cue Biopharma Inc | 22.1M | -0.7x | --- |
Evogene Ltd | 12.8M | -0.7x | --- |
Palatin Technologies Inc | 15.3M | -0.4x | --- |
COSCIENS Biopharma Inc | 15.9M | -0.4x | --- |
Correlate Energy Corp | 22.1M | -0.7x | --- |
Kineta Inc | 7.4M | -0.3x | --- |
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. Its two oncology drug product candidates, CUE-101 and CUE-102, are exemplary programs from the interleukin 2 (IL-2) based CUE-100 series, and are representative of the HLA-A02 allele, which is prevalent in the United States and western European territories. CUE-101 HLA-A02 is engineered for the treatment of human papillomavirus positive, head and neck squamous cell carcinoma (HNSCC). CUE-102 HLA-A02, targeting Wilms' Tumor 1 protein, an oncofetal antigen known to be over-expressed in more than 20 different cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.1M |
---|---|
Revenue (TTM) | $8.3M |
Shares Outstanding | 48.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.94 |
EPS | $-0.97 |
Book Value | $0.79 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 2.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -582.23% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.